Guardian Pharmacy Services (NYSE:GRDN) Cut to “Hold” at Wall Street Zen

Posted by George Bondi on Aug 4th, 2026

Wall Street Zen downgraded shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) from a buy rating to a hold rating in a research report report published on Saturday.

GRDN has been the subject of several other research reports. Oppenheimer increased their price objective on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Weiss Ratings downgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Bank of America lifted their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Finally, Zacks Research downgraded Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $42.83.

View Our Latest Report on GRDN

Guardian Pharmacy Services Stock Performance

GRDN stock opened at $40.69 on Friday. The company has a market cap of $2.03 billion, a P/E ratio of 49.03, a price-to-earnings-growth ratio of 2.59 and a beta of 0.11. Guardian Pharmacy Services has a fifty-two week low of $19.30 and a fifty-two week high of $44.00. The stock’s 50 day simple moving average is $40.76 and its 200 day simple moving average is $36.81.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The business had revenue of $336.60 million during the quarter, compared to analyst estimates of $329.89 million. During the same quarter in the previous year, the business posted $0.22 EPS. Guardian Pharmacy Services’s quarterly revenue was up 2.2% on a year-over-year basis. Equities analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently bought and sold shares of GRDN. Ameritas Investment Partners Inc. lifted its position in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth $43,000. State of Wyoming purchased a new stake in shares of Guardian Pharmacy Services during the 2nd quarter valued at $58,000. Strs Ohio bought a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth $75,000. Finally, Clearstead Advisors LLC lifted its holdings in shares of Guardian Pharmacy Services by 196.3% during the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after acquiring an additional 1,741 shares during the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.